These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 856307)
41. Evaluation of different treatment methods in patients with psoriasis and content of kallikrein and kallikreinogen in blood plasma. Kolosovsky ED Dermatology; 1994; 188(2):140-1. PubMed ID: 8136541 [TBL] [Abstract][Full Text] [Related]
42. [Use of aerosils in activating plasma prekallikrein]. Veremeenko KN; Pogorelaia NF Vopr Med Khim; 1979; 25(4):375-9. PubMed ID: 38571 [TBL] [Abstract][Full Text] [Related]
43. The kallikreinogen-kallikrein enzyme system of human plasma. Assay of components and observations in disease states. Colman RW; Mason JW; Sherry S Ann Intern Med; 1969 Oct; 71(4):763-73. PubMed ID: 5360288 [No Abstract] [Full Text] [Related]
44. Regulation of the formation and inhibition of human plasma kallikrein. Colman RW; Schapira M; Scott CF Ann N Y Acad Sci; 1981; 370():261-70. PubMed ID: 6943960 [No Abstract] [Full Text] [Related]
45. [Pattern of serum kallikreinogen-kallikrein system in patients with goiter]. Doliński J; Bielicki F; Lukieńczuk T; Witkiewicz W; Koziorowski A Endokrynol Pol; 1978; 29(1):31-4. PubMed ID: 580605 [No Abstract] [Full Text] [Related]
46. Molecular weight of human high-molecular-weight kininogen light chain by equilibrium sedimentation in an air-driven ultracentrifuge. Bock PE; Halvorson HR Anal Biochem; 1983 Nov; 135(1):172-9. PubMed ID: 6670737 [TBL] [Abstract][Full Text] [Related]
47. Structure-function relationships of human high MW kininogen related to contact activation of plasma. Kerbiriou DM; Griffin JH Adv Biosci; 1978 Jul; 17():205. PubMed ID: 755696 [No Abstract] [Full Text] [Related]
48. Activation of dog plasma kininogenase with glass. Nakahara M Biochem Pharmacol; 1974 Nov; 23(21):3009-15. PubMed ID: 4429598 [No Abstract] [Full Text] [Related]
49. Kininogen and kininogenase synthesis by the liver of normal and injured rats. Borges DR; Gordon AH J Pharm Pharmacol; 1976 Jan; 28(1):44-8. PubMed ID: 6649 [TBL] [Abstract][Full Text] [Related]
50. [Kallikreinogen determination in the plasma of various species]. Lehmann B; Kühne H; Scheuch DW Z Med Lab Diagn; 1981; 22(6):354-5. PubMed ID: 6177115 [No Abstract] [Full Text] [Related]
52. Comparison of cysteine-proteinases inhibitory properties of human high-molecular-weight-kininogen (HMrK) purified from plasma and serum. Pagano M Thromb Res; 1992 Jan; 65(2):121-9. PubMed ID: 1579889 [TBL] [Abstract][Full Text] [Related]
53. Purification of human serum prekallikrein, some properties of the purified proenzyme and its stability. Kawiak J; Kawalec M; Dotsenko VL; Yarovaya GA Clin Chim Acta; 1984 Aug; 141(2-3):287-92. PubMed ID: 6567485 [No Abstract] [Full Text] [Related]
54. Snake venoms, kallikreins, and kininogen. HABERMANN E Ann N Y Acad Sci; 1963 Feb; 104():130-2. PubMed ID: 13951649 [No Abstract] [Full Text] [Related]
55. Kallikrein system during treatment of hematological malignancies. Chiba Y; Ishihara H; Haneda Y; Yoshida Y Adv Exp Med Biol; 1979; 120A():501-9. PubMed ID: 291301 [TBL] [Abstract][Full Text] [Related]
56. On a Plasminogen Activator from Human Plasma. Diaz Batista A; Hernandez Solana G; Corral Almonte JF Thromb Haemost; 1979 Jul; 42(1):1607-1614. PubMed ID: 30781916 [TBL] [Abstract][Full Text] [Related]